diagnostics
| 2 min read
Under the new partnership, Biodesix will lead development and regulatory efforts for Bio-Rad’s ddPLEX ESR1 assay, enabling sensitive ctDNA-based mutation testing.
| 6 min read
New software and hardware tools that collect data while a person types can detect fine motor impairment — a possible sign of neurodegeneration.
| 3 min read
The POSEIDON program aims to create first-in-class synthetic sensor-based tests to detect over 30 cancers at Stage I using only non-invasive breath and urine samples.
| 2 min read
Activace platform enables targeted, genome-wide profiling of unmethylated DNA regions, providing a comprehensive view of the epigenome that can be scaled to the study of large patient cohorts
| 3 min read
Blood tests can’t diagnose Alzheimer’s disease yet, but one is already approved and more are on the way.
| 2 min read
Real-world data and KOL insights highlight MeMed BV’s supportive role in emergency medicine
| 3 min read
Largest molecular analysis to date reveals more than 100 blood biomarkers tied to the disease.
| 3 min read
Point-of-care tests that detect biomarkers from menstrual blood can enable broader access to disease monitoring and diagnosis.
| 4 min read
Learn about the Teal Wand™, an FDA-approved at-home HPV test from Teal Health. This self-collection test is expanding access to cervical cancer screening.
| 5 min read
From new biomarkers to smarter clinical trials, AI is transforming how cancer drugs are developed and how patients are diagnosed and treated.
